Ardian reinvests in Italian pharma business Neopharmed, NB Renaissance joins as investor
Global investment giant Ardian has reinvested in Italian pharmaceutical commercialisation business Neopharmed. The post Ardian reinvests in Italian pharma business Neopharmed, NB Renaissance joins as investor first appeared on AltAssets Private Equity News.
Recent Comments